Related by context. All words. (Click for frequent words.) 77 premenopausal breast cancer 71 endometrial cancer 67 colorectal adenomas 66 pre menopausal 66 colorectal adenoma 66 venous thrombosis 66 folate intake 65 colorectal neoplasia 65 cardiovascular mortality 65 spontaneous preterm delivery 65 cardiovascular disease 65 BRCA1 mutations 65 preterm delivery 64 polycystic ovary syndrome 64 hydroxyvitamin D levels 64 calcium supplementation 64 folate deficiency 64 magnesium intake 64 prostate cancer CaP 64 endometrial cancers 64 metabolic syndrome 63 polycystic ovary syndrome PCOS 63 atypical hyperplasia 63 gallstone disease 63 tibolone 63 endometrial hyperplasia 63 thyroid hormone levels 63 MetS 63 lobular breast cancer 63 colorectal cancer 63 BRCA2 mutations 62 heart disease 62 mammographic density 62 elevated CRP 62 folate supplementation 62 fasting glucose levels 62 elevated triglyceride levels 62 carotid IMT 62 perimenopausal women 62 advanced adenoma 62 hormone therapy estrogen 62 CVD mortality 62 haemorrhagic stroke 62 advanced adenomas 62 dysglycemia 62 estrogen progestin therapy 62 elevated LDL cholesterol 62 testosterone supplementation 62 oophorectomy 62 ductal breast cancer 62 lobular cancer 62 endogenous estrogen 62 endometrial carcinoma 62 coronary calcification 62 cerebral infarction 62 cardiorespiratory fitness 61 serum calcium 61 subclinical hypothyroidism 61 lignan intake 61 serum vitamin D 61 Wactawski Wende 61 HDL cholesterol 61 anovulatory infertility 61 BRCA mutations 61 spontaneous preterm birth 61 serum selenium 61 testicular germ cell 61 invasive breast cancer 61 subclinical atherosclerosis 61 recurrent miscarriage 61 BRCA mutation 61 cardiovascular morbidity 61 breast cancer recurrence 61 telomere lengths 61 polyp recurrence 61 elevated depressive symptoms 61 colorectal cancer incidence 61 serum calcium levels 61 carotid atherosclerosis 61 serum cholesterol 61 calcium intakes 61 prostate carcinogenesis 61 mammary tumors 61 disease NAFLD 61 nonfasting triglyceride levels 61 Ovary removal 60 MGUS 60 selenium supplementation 60 lipid abnormalities 60 preeclampsia 60 CLA supplementation 60 chlamydial infection 60 obese postmenopausal 60 beta carotene supplementation 60 beta carotene supplements 60 postoperative mortality 60 homocysteine levels 60 vertebral fracture 60 Leitzmann 60 lipoprotein 60 contralateral breast cancer 60 dietary folate intake 60 ovarian hormones 60 nonmelanoma skin cancer 60 atopic disease 60 cardio metabolic 60 premenopausal 60 thrombotic events 60 body fatness 60 T1DM 60 Ascherio 60 cerebral microbleeds 60 BRCA carriers 60 glycemic diet 60 postmenopausal women 60 postmenopausal hormone therapy 60 colorectal cancer CRC 60 BRCA2 mutation carriers 60 elevated triglycerides 60 postmenopausal hormones 60 calcium intake 60 modifiable risk 60 folic acid intake 60 dietary calcium intake 60 hereditary breast cancer 60 shorter telomeres 60 gestational diabetes mellitus 60 phytoestrogens 60 ductal cancer 60 RBP4 60 hippocampal volume 60 familial pancreatic cancer 60 recurrent miscarriages 60 telomere length 60 NAFLD 60 bowel polyps 59 premenopausal women 59 post menopausal 59 plasma homocysteine levels 59 endometriosis ovarian cysts 59 colorectal polyps 59 adiponectin levels 59 fructose intake 59 oropharyngeal cancer 59 Uterine cancer 59 LDL cholesterol levels 59 adenoma 59 postmenopausal 59 amino acid homocysteine 59 adiposity 59 HNSCC 59 vasomotor symptoms 59 basal cell nevus syndrome 59 dietary fiber intake 59 gestational hypertension 59 menarche 59 epithelial ovarian cancer 59 serum uric acid 59 urate levels 59 HIV HCV coinfected 59 brain shrinkage 59 adenoma recurrence 59 cardiovascular disease CVD 59 urinary oxalate 59 hip BMD 59 improves insulin sensitivity 59 BRCA mutation carriers 59 testicular tumors 59 INTERHEART study 59 ovarian cancer 59 serum IGF 59 arterial thickening 59 glucose intolerance 59 estrogen receptor negative 59 SHBG levels 59 recurrent VTE 59 CHD mortality 59 alpha carotene 59 subclinical hyperthyroidism 59 thrombophilia 59 modifiable lifestyle 59 intra abdominal fat 59 transferrin saturation 59 lung adenocarcinoma 59 bilateral oophorectomy 59 ApoE4 59 nonfasting triglycerides 59 colorectal tumors 59 soy isoflavones 59 homocysteine concentrations 59 tHcy 59 coronary heart 59 untreated celiac disease 59 acrylamide intake 58 dietary calcium 58 potentially modifiable 58 obese adolescents 58 arterial calcification 58 macrovascular disease 58 ABCB1 58 selenium intake 58 arterial stiffening 58 carotid stenosis 58 gamma tocopherol 58 invasive ductal 58 postmenopausal hormone replacement 58 BRCA gene mutations 58 plasma folate 58 Vitamin D supplementation 58 esophageal adenocarcinoma 58 bad cholesterol LDL 58 ovulatory cycles 58 bowel cancers 58 cosmetic breast implants 58 bladder cancers 58 thromboembolism 58 adrenal function 58 troponin T 58 serum lipid levels 58 clinically insignificant 58 nonpregnant women 58 vitamin D intake 58 postoperative AF 58 thyrotropin levels 58 serum phosphate 58 antiestrogen 58 plasma lipid 58 breast endometrial 58 paricalcitol 58 BRCA2 carriers 58 anal cancers 58 calorie diets 58 thyroid function 58 genetic variants associated 58 triglyceride concentrations 58 abdominal obesity 58 nonvertebral fractures 58 BRCA2 mutation 58 C reactive protein 58 gene variation 58 Framingham Offspring Study 58 neurodevelopmental outcome 58 dietary antioxidants 58 lipid levels 58 antioxidant nutrients 58 HDL C 58 adiponectin 58 Hilakivi Clarke 58 BRCA2 gene mutation 58 coronary disease 58 gene variants 58 APOE gene 58 premenstrual syndrome PMS 58 ovulatory infertility 58 fetal malformations 58 salpingo oophorectomy 58 uric acid levels 58 dose ionizing radiation 58 unmeasured factors 58 TT genotype 58 distal colon cancer 58 atherosclerosis 58 intima media thickness 58 elevated homocysteine 58 BRCA gene mutation 58 Reynolds Risk Score 58 saturated fat intake 58 vitamin D supplementation 58 Calcium intake 58 antioxidant supplementation 58 RBP4 levels 58 apoC III 58 preterm deliveries 58 aneuploidy 58 adenomas 58 β blockers 58 LV dysfunction 58 macrovascular 58 phytoestrogen intake 58 genetic polymorphisms 58 stone formers 57 Genetic variants 57 thromboembolic disease 57 statin medications 57 prostate pancreatic 57 colorectal carcinoma 57 pCR 57 leukaemias 57 serum homocysteine 57 shorter telomere length 57 osteopenic 57 triacylglycerol concentrations 57 carotid plaque 57 sudden cardiac death 57 aromatase inhibitors AIs 57 cardio vascular disease 57 coronary artery calcium 57 oesophageal cancer 57 cranial irradiation 57 ApoE4 gene 57 severe periodontitis 57 neurodevelopmental outcomes 57 knee OA 57 density lipoprotein cholesterol HDL 57 Vitamin D supplements 57 lipid profiles 57 metabolic disturbances 57 bone resorption 57 hyperinsulinemia 57 lowfat diet 57 atherosclerotic disease 57 cardio protective 57 triglyceride levels 57 orofacial clefts 57 venous blood clots 57 Hashimoto thyroiditis 57 Boffetta 57 Statin therapy 57 atypia 57 estrogen deficiency 57 primary ovarian insufficiency 57 metabolic parameters 57 cervical lesions 57 NPH insulin 57 density lipoprotein HDL cholesterol 57 colon polyps 57 plasma homocysteine 57 abnormal mammograms 57 urinary calcium 57 antigen PSA 57 LRP5 57 APOE e4 57 cancers 57 urinary tract symptoms LUTS 57 dexrazoxane 57 nondiabetic 57 atherogenic dyslipidemia 57 overt hepatic encephalopathy HE 57 serum LDL cholesterol 57 bone density 57 glycated hemoglobin levels 57 venous thromboembolism 57 arterial stiffness 57 esophageal squamous cell carcinoma 57 A1c levels 57 dyslipidaemia 57 SHBG 57 ovarian function 57 linoleic acids 57 oesophageal adenocarcinoma 57 PSA velocity 57 neural tube birth defects 57 gestational diabetes mellitus GDM 57 basal cell carcinoma BCC 57 coronary artery calcification 57 dose oral contraceptives 57 TZDs 57 lobular involution 57 Clinical Endocrinology & 57 EBV infection 57 cardiovascular disease hypertension 57 fat diets 57 renal cell carcinomas 57 breast cancer 57 chronic prostatitis 57 serum estradiol 57 Cochrane reviewers 57 Soy isoflavones 57 genetic variant 57 non fasting triglycerides 57 HDL2 57 genes BRCA1 57 esophageal cancers 57 ovarian cancers 57 artery calcification 57 perioperative morbidity 57 Adjuvant chemotherapy 57 systemic lupus erythematosus SLE 57 LDL cholesterol 57 cryptorchidism 57 hemorrhagic complications 57 Schunkert 57 density lipoprotein cholesterol 57 malignancies 57 APOE4 57 undergone hysterectomy 57 vitamin D deficiency 57 Darapladib 57 lowering homocysteine levels 57 Elevated triglycerides 57 colon tumors 57 VLDL cholesterol 57 ovarian carcinoma 57 noncancer 57 irregular menstrual cycles 56 recurrent UTI 56 insulin resistance 56 familial hypercholesterolemia 56 knee osteoarthritis 56 postoperative delirium 56 precancerous colon polyps 56 macrovascular events 56 fetal chromosomal 56 IUGR 56 osteoporotic fractures 56 premature menopause 56 dietary fat 56 gallstone formation 56 benign breast 56 uterine cancers 56 atherogenic 56 postmenopausal hormone 56 lobular carcinoma 56 Oestrogen 56 PCa 56 polycystic ovarian syndrome PCOS 56 Abdominal fat 56 T2D 56 LDLs 56 serum lipids 56 intensive statin therapy 56 vitamin D insufficiency 56 obstetric complications 56 SRBD 56 Cholesterol Levels SPARCL 56 CC genotype 56 genistein 56 estrogen metabolism 56 oestradiol 56 Erythropoietic therapies may 56 rectal cancers 56 carotid plaques 56 osteoporotic fracture 56 thiazide diuretics 56 nonmelanoma skin cancers 56 intravenous bisphosphonates 56 recurrent venous thromboembolism 56 vegetable intake 56 gene variant 56 narcolepsy cataplexy 56 serous ovarian cancer 56 pre eclampsia 56 atherosclerotic lesions 56 anorexia nervosa 56 oxidized phospholipids 56 testicular cancers 56 atherogenesis 56 mutated BRCA1 56 cholesterol HDL 56 tumor recurrence 56 serum concentrations 56 Lp PLA 2 56 androgen deprivation 56 abdominally obese 56 antioxidant supplements 56 plasma triglycerides 56 squamous cell cancers 56 abdominal adiposity 56 colorectal carcinogenesis 56 prolactin levels 56 serum creatinine levels 56 somatostatin analogs 56 onset diabetes mellitus 56 postoperative pulmonary 56 venlafaxine Effexor 56 Adequate vitamin D 56 hereditary predisposition 56 FGFR2 56 gastrointestinal cancers 56 glycemic index diets 56 APOE ε4 56 cardioprotective effects 56 myeloid leukemia 56 abnormal glucose tolerance 56 BRCA1 mutation carriers 56 pancreatic adenocarcinoma 56 SE alleles 56 periodontitis 56 locoregional recurrence 56 GnRH agonists 56 non aspirin NSAIDs 56 glitazones 56 elevated LDL 56 carotid artery thickness 56 de ath 56 androgen deficiency 56 VTEs 56 type2 diabetes 56 autoantibodies 56 NPY expression 56 liver transplant recipients 56 myocardial infarction MI 56 distant metastases 56 ischemic stroke 56 serum PSA 56 fasting insulin 56 denser breasts 56 Chlamydia infection 56 impair fertility 56 CaP 56 hypercholesterolaemia 56 H. pylori infection 56 nulliparous women 56 KIF6 carriers 56 dietary acrylamide 56 fasting triglyceride levels 56 nonvertebral fracture 56 thyroid dysfunction 56 vitamin D inadequacy 56 undergoing radical prostatectomy 56 Stomach cancer 56 grade gliomas 56 fetuin 56 elevated hsCRP 56 beta blocker therapy 56 Sexual dysfunction 56 subfertility 56 slow metabolizers 56 NNRTI resistance 56 HER2 expression 56 postmenopausal estrogen 55 metabolic abnormalities 55 Pischon 55 laryngeal cancer 55 autonomic dysfunction 55 fibrate drugs 55 carotid artery intima media 55 phytoestrogen 55 apolipoprotein E4 55 AAT deficiency 55 menopausal hormone therapy 55 MS relapses 55 coronary artery disease 55 BMI percentile 55 chemopreventive agent 55 Vigorous exercise 55 recurrent wheezing 55 biologic plausibility 55 cardioembolic stroke 55 Folic acid supplements 55 estrogen 55 metabolic syndrome MetS 55 periodontal disease 55 prostate cancer PCa 55 chromosomal rearrangement 55 bulimia nervosa 55 placental malaria 55 atrophic gastritis 55 undergoing bariatric surgery 55 amenorrhea 55 Lp PLA2 55 nondiabetics 55 mineral density 55 anastrozole 55 bone mineral 55 statin therapy 55 sFlt 1 55 serum leptin 55 juvenile idiopathic arthritis JIA 55 microvascular complications 55 hip fractures 55 blood lipids 55 folate 55 Oral contraceptives 55 precocious puberty 55 prostate cancers 55 normotensive 55 Hormone therapy 55 p# mutations 55 Homocysteine 55 familial adenomatous polyposis 55 poorer prognosis 55 fructose diet 55 axillary node 55 breast carcinoma 55 hypertension diabetes mellitus 55 HER2 positive cancers 55 Singh Manoux 55 lipid lowering drugs 55 atherosclerosis hardening 55 benign growths 55 NAT2 55 thigh circumference 55 prostate cancer CRPC 55 vascular dysfunction 55 TCF#L# gene 55 insulin sensitivity 55 Triglyceride levels 55 circulating estrogens 55 ovarian pancreatic 55 PTPN# 55 serum PTH 55 antioxidant intake 55 CHD CVD 55 Avandia Actos 55 estrogen metabolites 55 B7 H3 55 osteoporosis 55 asymptomatic carotid stenosis 55 hepatic glucose production 55 endocrine tumors 55 Estrogen therapy 55 chronic periodontitis 55 chromosomal instability 55 endothelial dysfunction 55 metachronous 55 kaempferol 55 HNPCC 55 albuminuria 55 strontium ranelate 55 antihypertensive therapy 55 ovaries removed 55 hemoglobin A1c levels 55 LDL oxidation 55 osteosarcomas 55 psychotic illnesses 55 hsCRP 55 epigenetic changes 55 microvascular disease 55 prepubertal 55 obesity insulin resistance 55 endometrial thickness 55 chorioamnionitis 55 cancerdefine 55 dysfunctional voiding 55 polycystic ovaries 55 TGFBR1 * 6A 55 Folate deficiency 55 basal cell carcinomas 55 invasive ductal breast cancer 55 serum folate 55 GSTM1 55 serum testosterone levels 55 cutaneous melanoma 55 GSTM1 gene 55 bezafibrate 55 Menopausal hormone therapy 55 vitamin B# deficiency 55 STAT4 55 faulty BRCA genes 55 CETP inhibition 55 axillary lymph nodes 55 cholesterols 55 atherothrombotic events 55 prolongs survival 55 tamoxifen 55 Secondhand smoke exposure 55 endogenous hormones 55 fatty liver disease 55 serum urate levels 55 Calcium supplements 55 estrogen therapy 55 postoperative complications 55 fatal IHD 55 HbA1C levels 55 SORL1 55 sodium valproate 55 familial clustering 55 2 diabetes T2D 55 bronchopulmonary dysplasia 55 breast cancers 55 Rectal cancer 55 insulin resistance syndrome 55 serum BDNF 55 rs# [002] 55 precancerous cervical 55 frequently benign tumor 55 SERMs 55 serum triglycerides 55 overt hypothyroidism 55 lipid lowering medications 55 homozygous familial hypercholesterolemia 55 ADPKD 55 invasive carcinoma 55 cholesterol LDL C 55 conjugated estrogen 55 inflammatory rheumatic 55 dietary folate 55 insulin sensitizing 55 mitochondrial fusion 55 Premature menopause 55 systolic hypertension 55 PIGF 55 mixed hyperlipidemia 55 urolithiasis 55 CIN3 55 intestinal polyps 55 dose aspirin 55 lipid lowering therapy 55 colorectal cancers 55 confidence interval #.#-#.# 55 CETP gene 55 PARP inhibition 55 Prostate Cancer Prevention 55 aminotransferases 55 childhood sunburns 55 pathologic fractures 55 N telopeptide 55 ductal carcinomas 55 neoplasia 55 metabolic syndrome clustering 55 antihypertensive medications 55 neutrophil counts 55 genetic variants 55 Genetic variation 55 Radical prostatectomy 55 severe psoriasis 54 prostate cancer 54 colon cancer 54 multivitamin supplements 54 PROSTVAC VF 54 naturally occurring estrogen 54 menthol smokers 54 asymptomatic PAD 54 ovarian tumors 54 vitamin E 54 extrapyramidal symptoms 54 glycemic diets 54 nephrolithiasis 54 osteopenia 54 APOE e4 allele 54 folates 54 neurodevelopmental impairment 54 uterine tumors 54 valvulopathy 54 cystatin C 54 GH deficiency 54 CMV infection 54 serum triglyceride levels 54 primary hypercholesterolemia 54 AUDs 54 androgen suppression therapy 54 lymphatic cancers 54 hyperhomocysteinemia 54 VTE 54 breast cancer metastasis 54 Lowering cholesterol 54 PTEN mutations 54 Sjögren syndrome 54 CARDIA study 54 pleural mesothelioma 54 Michael F. Leitzmann 54 histological subtype 54 LQTS 54 HGPIN 54 inflammatory markers 54 Genetic predisposition 54 BRCA1 mutation 54 Helicobacter pylori infection 54 fat diet 54 thyrotropin 54 brain lesions 54 coinfection 54 relapsed ALL 54 nondrinkers 54 Prehypertension 54 osteoporosis brittle bones 54 sporadic ALS 54 enterolactone 54 HER2 overexpression 54 dietary glycemic index 54 cirrhotic patients 54 Subgroup analyzes 54 rs# [001] 54 Cognitive impairment 54 hematopoietic cancers 54 Premenopausal women 54 inflammatory polyarthritis 54 islet autoimmunity 54 atypical fractures 54 haemorrhagic strokes 54 breast cancer genes BRCA1 54 transaminase levels 54 flutamide 54 unmeasured confounders 54 habitual snoring 54 hemorrhagic strokes 54 hawthorn extract 54 PHPT 54 mtDNA mutations 54 NHANES III 54 nocturnal hypoglycaemia 54 plasma selenium 54 MYCN amplification 54 periodontal gum disease 54 drank colas 54 APOC3 54 abnormal lipid levels 54 Nordestgaard 54 exemestane 54 atypical femur fractures 54 fatty acid oxidation 54 pre eclamptic 54 EpCAM expression 54 aneurysmal subarachnoid hemorrhage 54 G allele 54 serum parathyroid hormone 54 p#INK#a 54 DHEAS 54 dietary intakes 54 folic acid supplementation 54 TCF#L# 54 invasive lobular 54 fasting glucose 54 follicle stimulating hormone FSH 54 DFMO 54 androgen therapy 54 lung cancer 54 antidiabetic medication 54 rs# [003] 54 muscle protein synthesis 54 oncogenic HPV 54 lymph node involvement 54 progranulin 54 serum testosterone 54 mIU L 54 dietary supplementation 54 abnormal lipid 54 RYGB surgery 54 lowering LDL cholesterol 54 HbA1c levels 54 definite stent thrombosis 54 thromboembolic events 54 thrombotic complications 54 Lung transplantation 54 PBDE chemicals 54 aromatase inhibitor therapy 54 isoflavones 54 eosinophil count 54 recurrent UTIs 54 cisplatin resistant 54 varicocele 54 atypical ductal hyperplasia 54 Heavy snorers 54 sex hormone estrogen 54 nondiabetic patients 54 paroxetine Paxil 54 variceal bleeding 54 noncarriers 54 estrone 54 DASH diet 54 palmitoleate 54 antenatal depression 54 penetrance 54 T2DM 54 Fas ligand 54 rimonabant #mg 54 intracerebral hemorrhage 54 thromboembolic complications 54 gastric cancer 54 colorectal polyp 54 KIBRA 54 postnatally 54 acute GVHD 54 asthma exacerbations 54 metastatic prostate cancer 54 GSTT1 54 breast tenderness 54 mild gestational diabetes 54 CYP#D# inhibitor 54 APOE e4 gene 54 DHEA supplementation 54 adiponectin concentrations 54 highest tertile 54 depressive symptomatology 54 APOL1 54 hypovitaminosis D 54 oxidized LDL 54 hydroxychloroquine 54 Androgen deprivation therapy 54 atherosclerotic progression 54 MMSE scores 54 fragility fractures 54 Clinical Endocrinology 54 biochemical recurrence 54 bisphosphonate drugs 54 noncardiovascular 54 Calcium supplementation 54 atherosclerotic vascular disease 54 familial ALS 54 white matter hyperintensities 54 lowering homocysteine 54 iodine intake 54 residual confounding 54 lignans 54 hypoglycemic episodes 54 HeFH 54 lung metastasis 54 faulty BRCA2 gene 54 IPAH 54 HDL LDL ratio 54 #mg/dL [001] 54 endometrial 54 abstinent alcoholics 54 atopy 54 reproductive hormones 54 plasma lipids 54 HMG CoA reductase inhibitors 54 oral leukoplakia 54 2D 4D ratio 54 UCP2 54 venous thromboembolic events 54 preoperative PSA 54 LDL cholesterol concentrations 54 serum GGT 54 HPV infection 54 chlamydia infections 54 mcg dL 54 cruciferous vegetables 54 placenta praevia 54 albumin excretion 54 Suicidal tendencies 54 dietary intake 54 MTHFR 54 Coronary artery calcification 54 Dr. Sudha Seshadri 54 chromium supplementation 54 dietary sodium 54 Myocardial infarction 54 differentiated thyroid 54 upper gastrointestinal bleeding 54 lichen planus 54 neuroblastomas 54 HbA 1c 54 inflammatory biomarkers 54 colorectal neoplasms 54 elevated uric acid 54 Demark Wahnefried 54 pre pubertal 54 PON1 activity 54 leiomyomas 54 B# deficiency 54 brain atrophy 54 atherothrombosis 54 nondemented 54 Adiponectin 54 platelet activation 54 thromboembolic 54 Bresalier 54 diabetes mellitus 54 tumor subtype 54 cardiac hypertrophy 54 homocysteine 54 invasive candidiasis 54 Breast Cancer Risk 54 abdominal fat 54 systolic dysfunction 54 Kivipelto 53 osteoporotic 53 sulphonylureas 53 polycystic ovarian syndrome 53 Grodstein 53 K ras mutations 53 Prostatitis 53 nicotine dependence 53 LDL Cholesterol 53 Antioxidant supplements 53 FTO gene 53 ApoA1 53 CIN2 + 53 rectal cancer 53 prostate specific 53 Estrogens 53 hsCRP levels 53 vascular inflammation 53 tamoxifen raloxifene 53 gestational diabetes 53 reinfarction 53 hyperkalemia 53 advanced neoplasia 53 SORT OUT III 53 DMPA 53 angiotensin receptor blockers 53 femoral neck BMD 53 atherothrombotic disease 53 aneuploid cells 53 urate 53 dentinal hypersensitivity 53 handgrip strength 53 tumor subtypes 53 hydroxymethyl coenzyme 53 abnormal Pap test 53 protein excretion 53 MC1R 53 density lipoprotein 53 behavioral disinhibition 53 silent ischemia 53 preeclamptic 53 fluvastatin 53 waist circumferences 53 microbleeds 53 gene polymorphism 53 central adiposity 53 loop diuretics 53 trivial Klatsky 53 relapsed ovarian cancer 53 PSADT 53 EGFR mutations 53 cardiovascular